Neil Gunn - 01 Jun 2025 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role
Director
Signature
/s/ Ali Olivo, Attorney-in-Fact
Issuer symbol
NEO
Transactions as of
01 Jun 2025
Net transactions value
$0
Form type
4
Filing time
03 Jun 2025, 16:07:02 UTC
Previous filing
07 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Gunn Neil Director 9490 NEOGENOMICS WAY, FORT MYERS /s/ Ali Olivo, Attorney-in-Fact 03 Jun 2025 0001984436

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEO Common Stock Options Exercise $0 +12,254 +77% $0.000000 28,100 01 Jun 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEO Restricted Stock Unit Options Exercise $0 -12,254 -100% $0.000000 0 01 Jun 2025 Common Stock 12,254 $0.000000 Direct F2
transaction NEO Stock Option (Right to Buy) Award $0 +16,107 $0.000000 16,107 01 Jun 2025 Common Stock 16,107 $7.28 Direct
transaction NEO Restricted Stock Unit Award $0 +23,077 $0.000000 23,077 01 Jun 2025 Common Stock 23,077 $0.000000 Direct F2
holding NEO Stock Option (Right to Buy) 8,353 01 Jun 2025 Common Stock 8,353 $14.82 Direct
holding NEO Stock Option (Right to Buy) 8,672 01 Jun 2025 Common Stock 8,672 $13.71 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects release of restricted stock units that were previously reported on a Form 4.
F2 Once vested, the shares of common stock are not subject to expiration.